Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT06000683
Official study title

Empowering Patients' Lung Cancer Screening Uptake

Study summary

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedPatient education and Referral to financial navigation resources

Plus 2 other study approaches.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 20, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?7 U.S. locations

Locations may change over time.

Who runs it?University of California, Irvine

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of California, Irvine
Interventions being studied
Behavioral: Patient education; Behavioral: Referral to financial navigation resources; Behavioral: Patient Reminders; Behavioral: Provider Reminers
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients' 1. Aged 50- 80 years of age. 2. Be able to Speak English, Spanish, or Vietnamese 3. Must have a scheduled appointment with their Primary Care Providers within next one to three months. 4. The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers 5. History of 20 pack year smoking history ( based on survey self report) 6. Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report) Patients'

Reasons someone may not be able to joinExclusion criteria

1. Prior history of lung cancer 2. chest CT for any reason in the last 12 months based on self-report and UCI EMR 3. history of Alzheimer's disease or dementia Providers' Inclusion Criteria: 1. Primary Care Providers whose patients were enrolled in the Empower LCS trial. 2. Received notifications about the eligibility of their patients for lung cancer screening.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • UCI Health - Costa MesaCosta Mesa, California
  • UCI Health Gottschalk Medical PlazaIrvine, California
  • UCI Health - Laguna HillsLaguna Hills, California
  • UCI Health - Newport Beach MacArthurNewport Beach, California
  • UCI Medical CenterOrange, California
  • UCI Health - TustinTustin, California
  • UCI Health-Yorba LindaYorba Linda, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 20, 2026. Always confirm current availability with the study team.

View original record ↗